Brian A. Kirk

Statistics

Publications

Citations

448

H-Index

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Rutgers, The State University of New Jersey

University of British Columbia

Brian A. Kirk is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1994–2013

Publications

NAG-thiazoline, An <i>N</i>-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation

Spencer Knapp, David J. Vocadlo, Zhinong Gao et al. · Journal of the American Chemical Society · 1996 · 246 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor

Joseph Duffy, Brian A. Kirk, Zenon Konteatis et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State

Benoit J. Smagghe, Andrew K. Stewart, Mark G. Carter et al. · PLoS ONE · 2013 · 26 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

.alpha.- and .beta.-Deuterium Isotope Effects in the MgX2 and Methylaluminoxane Promoted Intramolecular Olefin Insertion of Cp2TiClR Complexes. Insight into Cocatalyst Dependence and Chain End Control in Ziegler-Natta Polymerization

Nancy S. Barta, Brian A. Kirk, John R. Stille · Journal of the American Chemical Society · 1994 · 19 citations

Natural Sciences, Chemistry, Catalysis +13

4-Aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV

Joseph Duffy, Brian A. Kirk, Liping Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 11